Encompass Health Director Acquires Shares via Deferral Plan and Dividend Reinvestment
Encompass Health Corp
Subscribe to track EHC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ Insider Transaction Report: Encompass Health Corp ($EHC)
Insider: Edward M. Christie III (Director) Filing Date: October 19, 2026 Transaction Summary: ā¢ Acquired: 232 shares total
- 11 RSUs via dividend reinvestment ($0.00)
- 221 shares via Directors Deferred Stock Investment Plan @ $126.63 avg ($27,985.23 total) ā¢ Post-Transaction Holdings: 9,577 shares ā¢ Significance: Low (Routine quarterly director fee deferral and dividend equivalent crediting)
Comprehensive Analysis
Encompass Health Corp ($EHC) Form 4 Filing Analysis
Overview
On October 19, 2026, Director Edward M. Christie III reported the acquisition of common stock and dividend equivalent restricted stock units (RSUs) of Encompass Health Corp:
- October 15, 2026: Credited 11 RSUs at $0.00 in connection with the company's regular quarterly dividend payment ($0.21 per share) based on the closing price of $127.77.
- October 19, 2026: Purchased 221 shares of common stock at a weighted average price of $126.63 (ranging from $126.62 to $126.73) through the Directors Deferred Stock Investment Plan utilizing deferred quarterly director fees and dividend reinvestment, for an aggregate value of approximately $27,985.23.
Following these transactions, Mr. Christie directly holds 9,577 shares.
Market Impact & Trading Significance
The trading significance is assessed as Low. These acquisitions represent standard, pre-scheduled director compensation arrangements involving fee deferrals and automated dividend reinvestment rather than discretionary open-market insider buying based on material non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.